Switching of pyruvate kinase isoform L to M2 promotes metabolic reprogramming in hepatocarcinogenesis.

MLA

Wong, Carmen Chak-Lui, et al. “Switching of Pyruvate Kinase Isoform L to M2 Promotes Metabolic Reprogramming in Hepatocarcinogenesis.” PloS One, vol. 9, no. 12, Dec. 2014, p. e115036. EBSCOhost, https://doi.org/10.1371/journal.pone.0115036.

APA

Wong, C. C.-L., Au, S. L.-K., Tse, A. P.-W., Xu, I. M.-J., Lai, R. K.-H., Chiu, D. K.-C., Wei, L. L., Fan, D. N.-Y., Tsang, F. H.-C., Lo, R. C.-L., Wong, C.-M., & Ng, I. O.-L. (2014). Switching of pyruvate kinase isoform L to M2 promotes metabolic reprogramming in hepatocarcinogenesis. PloS One, 9(12), e115036. https://doi.org/10.1371/journal.pone.0115036

Chicago

Wong, Carmen Chak-Lui, Sandy Leung-Kuen Au, Aki Pui-Wah Tse, Iris Ming-Jing Xu, Robin Kit-Ho Lai, David Kung-Chun Chiu, Larry Lai Wei, et al. 2014. “Switching of Pyruvate Kinase Isoform L to M2 Promotes Metabolic Reprogramming in Hepatocarcinogenesis.” PloS One 9 (12): e115036. doi:10.1371/journal.pone.0115036.